CANN GROUP LTD ORDINARY (CAN) Short Interest
CANN GROUP LTD ORDINARY (ASX:CAN) had 4.39% of shares reported as short positions as of 21 July 2026, representing 42,263,544 shares. CANN GROUP LTD ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Cann Group
Cann Group is an Australian pharmaceutical company focused on cultivating cannabis for medicinal and research purposes. They manufacture medicinal cannabis products, aiming to be a national benchmark for R&D and production processes. The company strives to improve the quality of life for patients through ethical leadership in the emerging medical cannabis industry.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4CAN intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Cann Group
Latest CAN news
All newsAbout
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss CAN
Start a research thread or post the first pulse update